Filing Details
- Accession Number:
- 0001144204-15-032293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-19 16:09:34
- Reporting Period:
- 2015-05-18
- Filing Date:
- 2015-05-19
- Accepted Time:
- 2015-05-19 16:09:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457896 | William Ted Karkus | 621 N. Shady Retreat Road Doylestown PA 18901 | Ceo & Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0005 | Acquisiton | 2015-05-18 | 10,496 | $1.34 | 2,275,084 | No | 4 | P | Direct | |
Common Stock, Par Value $0.0005 | Acquisiton | 2015-05-19 | 199,504 | $1.35 | 2,474,588 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.34, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive.